Its important to approach GLP-1 therapy judiciously, when its clinically appropriate, with the intent to eventually transition people away from perpetual dependence on these medications through lifestyle interventions such as healthy eating and physical activity
These are typically most noticeable in the first few weeks or right after a dose change, and can include nausea, diarrhea, constipation, fatigue, and abdominal pain
Description Research Overview Retatrutide is a synthetic multi-receptor investigational peptide studied for coordinated signalling across the GLP-1, GIP, and glucagon receptor systems
The 2017 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure guidelines list corticosteroids as a recognized cause of secondary hypertension and recommend screening for steroid use in any patient with treatment-resistant elevations [6]
Many people taking Wegovy (semaglutide) for weight management wonder whether they can still enjoy occasional treats like ice cream